Literature DB >> 36221938

Elderly CADASIL patients with intact neurological status.

Ruiting Zhang1,2, Elisa Ouin3, Lina Grosset1,4, Karine Ighilkrim5, Jessica Lebenberg1,4, Stéphanie Guey1,4, Véronique François5, Elisabeth Tournier-Lasserve1,6, Eric Jouvent1,4, Hugues Chabriat1,4.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is one of the most devastating cerebral small vessel diseases. However, despite its progression with aging, some patients remain neurologically intact (Nint) even when they get older. Their main characteristics are poorly known. We aimed to delineate their clinical, imaging, and molecular features.
METHODS: Individuals aged over 65 years were selected from a cohort of 472 CADASIL patients. Subjects who had no focal deficit, cognitive impairment, or disability were considered Nint. Their demographic, genetic, clinical, and imaging features were compared to those with permanent neurological symptoms (Nps).
RESULTS: Among 129 patients, 23 (17.8%) individuals were considered Nint. The frequency of vascular risk factors and NOTCH3 cysteine mutations in epidermal growth factor-like repeat (EGFr) domains 7-34 did not differ between Nint and Nps patients but Nint patients had less stroke events and were more likely to have migraine with aura. The number of lacunes and microbleeds and degree of brain atrophy were lower in the Nint group, but the volume of white matter hyperintensities did not differ between the two groups.
CONCLUSIONS: Nearly one in five CADASIL patients can remain Nint after the age of 65 years. Their clinical and imaging profile differed from that of other age-matched CADASIL patients. The location of NOTCH3 mutation inside or outside EGFr domains 1-6 cannot fully explain this discrepancy. The factors involved in their relative preservation of brain tissue from severe damage despite aging remain to be determined.

Entities:  

Keywords:  Aging; CADASIL; Cerebral small vessel diseases; Magnetic resonance imaging; Mutation

Year:  2022        PMID: 36221938      PMCID: PMC9561215          DOI: 10.5853/jos.2022.01578

Source DB:  PubMed          Journal:  J Stroke        ISSN: 2287-6391            Impact factor:   8.632


  39 in total

1.  Cognitive profile in CADASIL patients.

Authors:  L Caeiro; J M Ferro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

2.  The remarkably variable expressivity of CADASIL: report of a minimally symptomatic man at an advanced age.

Authors:  Yi-Chung Lee; An-Hang Yang; Bing-Wen Soong
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  Identification of a novel NOTCH3 mutation in an Italian family affected by a mild form of CADASIL.

Authors:  Enrico Ferrante; Lorena Mosca; Cristina Erminio; Silvana Penco; Ugo Cavallari
Journal:  Neurol Sci       Date:  2019-03-01       Impact factor: 3.307

4.  Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI.

Authors:  François De Guio; Alexandre Vignaud; Hugues Chabriat; Eric Jouvent
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-27       Impact factor: 6.200

Review 5.  Cadasil.

Authors:  Hugues Chabriat; Anne Joutel; Martin Dichgans; Elizabeth Tournier-Lasserve; Marie-Germaine Bousser
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

6.  A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient.

Authors:  Francesca Pescini; Silvia Bianchi; Emilia Salvadori; Anna Poggesi; Maria Teresa Dotti; Antonio Federico; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol Sci       Date:  2007-11-19       Impact factor: 3.181

7.  Prevalence and characteristics of migraine in CADASIL.

Authors:  Stephanie Guey; Jérôme Mawet; Dominique Hervé; Marco Duering; Ophelia Godin; Eric Jouvent; Christian Opherk; Nassira Alili; Martin Dichgans; Hugues Chabriat
Journal:  Cephalalgia       Date:  2016-07-11       Impact factor: 6.292

8.  Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL.

Authors:  Eric Jouvent; Anand Viswanathan; Jean-François Mangin; Mike O'Sullivan; Jean-Pierre Guichard; Andreas Gschwendtner; Rodica Cumurciuc; Frédérique Buffon; Nils Peters; Chahin Pachaï; Marie-Germaine Bousser; Martin Dichgans; Hugues Chabriat
Journal:  Stroke       Date:  2007-04-19       Impact factor: 7.914

9.  Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.

Authors:  Gido Gravesteijn; Johannes G Dauwerse; Maurice Overzier; Gwendolyn Brouwer; Ingrid Hegeman; Aat A Mulder; Frank Baas; Mark C Kruit; Gisela M Terwindt; Sjoerd G van Duinen; Carolina R Jost; Annemieke Aartsma-Rus; Saskia A J Lesnik Oberstein; Julie W Rutten
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.